RecruitingMetastatic Colorectal Cancer
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Eligible age
18–130 yrs
Accepts
All genders
Locations
14 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).
Sponsor: AstraZeneca
Where it's recruiting
Arizona
Scottsdale
California
Los Angeles
District of Columbia
Washington D.C.
Illinois
Chicago
Maryland
Baltimore
Massachusetts
Boston
Minnesota
Rochester
New Jersey
Trenton
New York
Rochester
Ohio
Cleveland
Oregon
Portland
Pennsylvania
Philadelphia
Source: ClinicalTrials.gov · NCT06792695 · last updated 2026-07-13